Liver transplantation for malignancies in children

Liver Transplantation

Volumn 16, Issue SUPPL. 2, 2010, Pages

  McDiarmid, Sue V ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOXORUBICIN; FLUOROURACIL; VINCRISTINE;

ARTICLE; CANCER CHEMOTHERAPY; CANCER STAGING; CHILD; CHILDHOOD CANCER; HEPATOBLASTOMA; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TRANSPLANTATION; LUNG METASTASIS; PRIORITY JOURNAL;

EID: 78651391976     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.22170     Document Type: Article

References (38)

1. Evans AE, Land VJ, Newton WA, Randolph JG, Sather HN, Tefft M,. Combination chemotherapy (vincristine, adriamycin, cyclophosphamide, and 5-fluorouracil) in the treatment of children with malignant hepatoma. Cancer 1982; 50: 821-826.
2. Kosola S, Lauronen J, Sairanen H, Heikinheimo M, Jalanko H, Pakarinen M,. High survival rates after liver transplantation for hepatoblastoma and hepatocellular carcinoma. Pediatr Transplant 2010; 14: 646-650.
3. Beaunoyer M, Vanatta JM, Ogihara M, Strichartz D, Dahl G, Berquist WE, et al. Outcomes of transplantation in children with primary hepatic malignancy. Pediatr Transplant 2007; 11: 655-660. (Pubitemid 47174400)
4. Finegold MJ, Egler RA, Goss JA, Guillerman RP, Karpen SJ, Krishnamurthy R, et al. Liver tumors: pediatric population. Liver Transpl 2008; 14: 1545-1556.
5. Otte JB,. Progress in the surgical treatment of malignant liver tumors in children. Cancer Treat Rev 2010; 36: 360-371.
6. Ikeda H, Hachitanda Y, Tanimura M, Maruyama K, Koizumi T, Tsuchida Y,. Development of unfavorable hepatoblastoma in children of very low birth weight: results of a surgical and pathologic review. Cancer 1998; 82: 1789-1796. (Pubitemid 28208932)
7. Litten JB, Tomlinson GE,. Liver tumors in children. Oncologist 2008; 13: 812-820.
8. Spector LG, Johnson KJ, Soler JT, Puumala SE,. Perinatal risk factors for hepatoblastoma. Br J Cancer 2008; 98: 1570-1573.
9. Buckley JD, Sather H, Ruccione K, Rogers PC, Haas JE, Henderson BE, et al. A case-control study of risk factors for hepatoblastoma. A report from the Childrens Cancer Study Group. Cancer 1989; 64: 1169-1176. (Pubitemid 19208876)
10. Schnater JM, Aronson DC, Plaschkes J, Perilongo G, Brown J, Otte JB, et al. Surgical view of the treatment of patients with hepatoblastoma: results from the first prospective trial of the International Society of Pediatric Oncology Liver Tumor Study Group. Cancer 2002; 94: 1111-1120. (Pubitemid 34150867)
11. Haas JE, Muczynski KA, Krailo M, Ablin A, Land V, Vietti TJ, et al. Histopathology and prognosis in childhood hepatoblastoma and hepatocarcinoma. Cancer 1989; 64: 1082-1095. (Pubitemid 19208862)
12. Brown J, Perilongo G, Shafford E, Keeling J, Pritchard J, Brock P, et al. Pretreatment prognostic factors for children with hepatoblastoma-results from the International Society of Paediatric Oncology (SIOP) study SIOPEL 1. Eur J Cancer 2000; 36: 1418-1425. (Pubitemid 30421147)
13. Otte JB, Pritchard J, Aronson DC, Brown J, Czauderna P, Maibach R, et al. Liver transplantation for hepatoblastoma: results from the International Society of Pediatric Oncology (SIOP) study SIOPEL-1 and review of the world experience. Pediatr Blood Cancer 2004; 42: 74-83. (Pubitemid 38173460)
14. Roebuck DJ, Aronson D, Clapuyt P, Czauderna P, de Ville de Goyet J, Gauthier F, et al. 2005 PRETEXT: a revised staging system for primary malignant liver tumours of childhood developed by the SIOPEL group. Pediatr Radiol 2007; 37: 123-132. (Pubitemid 46092102)
15. Aronson DC, Schnater JM, Staalman CR, Weverling GJ, Plaschkes J, Perilongo G, et al. Predictive value of the Pretreatment Extent of Disease system in hepatoblastoma: results from the International Society of Pediatric Oncology Liver Tumor Study Group SIOPEL-1 study. J Clin Oncol 2005; 23: 1245-1252. (Pubitemid 46202282)
16. Finegold MJ,. Chemotherapy for suspected hepatoblastoma without efforts at surgical resection is a bad practice. Med Pediatr Oncol 2002; 39: 484-486.
17. Ortega JA, Douglass EC, Feusner JH, Reynolds M, Quinn JJ, Finegold MJ, et al. Randomized comparison of cisplatin/vincristine/fluorouracil and cisplatin/continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: a report from the Children's Cancer Group and the Pediatric Oncology Group. J Clin Oncol 2000; 18: 2665-2675. (Pubitemid 30463548)
18. Faraj W, Dar F, Marangoni G, Bartlett A, Melendez HV, Hadzic D, et al. Liver transplantation for hepatoblastoma. Liver Transpl 2008; 14: 1614-1619.
19. Zsiros J, Maibach R, Shafford E, Brugieres L, Brock P, Czauderna P, et al. Successful treatment of childhood high-risk hepatoblastoma with dose-intensive multiagent chemotherapy and surgery: final results of the SIOPEL-3HR study. J Clin Oncol 2010; 28: 2584-2590.
20. Austin MT, Leys CM, Feurer ID, Lovvorn HN III, O'Neill JA Jr, Pinson CW, et al. Liver transplantation for childhood hepatic malignancy: a review of the United Network for Organ Sharing (UNOS) database. J Pediatr Surg 2006; 41: 182-186.
21. Browne M, Sher D, Grant D, Deluca E, Alonso E, Whitington PF, et al. Survival after liver transplantation for hepatoblastoma: a 2-center experience. J Pediatr Surg 2008; 43: 1973-1981.
22. Kasahara M, Ueda M, Haga H, Hiramatsu H, Kobayashi M, Adachi S, et al. Living-donor liver transplantation for hepatoblastoma. Am J Transplant 2005; 5: 2229-2235. (Pubitemid 41648470)
23. Reyes JD, Carr B, Dvorchik I, Kocoshis S, Jaffe R, Gerber D, et al. Liver transplantation and chemotherapy for hepatoblastoma and hepatocellular cancer in childhood and adolescence. J Pediatr 2000; 136: 795-804. (Pubitemid 30415656)
24. Czauderna P, Mackinlay G, Perilongo G, Brown J, Shafford E, Aronson D, et al. Hepatocellular carcinoma in children: results of the first prospective study of the International Society of Pediatric Oncology group. J Clin Oncol 2002; 20: 2798-2804. (Pubitemid 34651508)
25. Katzenstein HM, Krailo MD, Malogolowkin MH, Ortega JA, Liu-Mares W, Douglass EC, et al. Hepatocellular carcinoma in children and adolescents: results from the Pediatric Oncology Group and the Children's Cancer Group intergroup study. J Clin Oncol 2002; 20: 2789-2797. (Pubitemid 34651507)
26. Shen DW, Lu YG, Chin KV, Pastan I, Gottesman MM,. Human hepatocellular carcinoma cell lines exhibit multidrug resistance unrelated to MRD1 gene expression. J Cell Sci 1991; 98: 317-322. (Pubitemid 21924980)
27. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693-699. (Pubitemid 26079803)
28. Yao FY, Ferrell L, Bass NM, Watson JJ, Bacchetti P, Venook A, et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 2001; 33: 1394-1403. (Pubitemid 32496976)
29. Kim H, Lee MJ, Kim MR, Chung IP, Kim YM, Lee JY, et al. Expression of cyclin D1, cyclin E, cdk4 and loss of heterozygosity of 8p, 13q, 17p in hepatocellular carcinoma: comparison study of childhood and adult hepatocellular carcinoma. Liver 2000; 20: 173-178. (Pubitemid 30219145)
30. Ismail H, Broniszczak D, Kalicinski P, Markiewicz-Kijewska M, Teisseyre J, Stefanowicz M, et al. Liver transplantation in children with hepatocellular carcinoma. Do Milan criteria apply to pediatric patients? Pediatr Transplant 2009; 13: 682-692.
31. Lo CM, Fan ST, Liu CL, Chan SC, Wong J,. The role and limitation of living donor liver transplantation for hepatocellular carcinoma. Liver Transpl 2004; 10: 440-447. (Pubitemid 38380321)
32. Arikan C, Kilic M, Nart D, Ozgenc F, Ozkan T, Tokat Y, et al. Hepatocellular carcinoma in children and effect of living-donor liver transplantation on outcome. Pediatr Transplant 2006; 10: 42-47.
33. Guiteau JJ, Cotton RT, Karpen SJ, O'Mahony CA, Goss JA,. Pediatric liver transplantation for primary malignant liver tumors with a focus on hepatic epithelioid hemangioendothelioma: the UNOS experience. Pediatr Transplant 2010; 14: 326-331.
34. Woodall CE, Scoggins CR, Lewis AM, McMasters KM, Martin RC,. Hepatic malignant epithelioid hemangioendothelioma: a case report and review of the literature. Am Surg 2008; 74: 64-68. (Pubitemid 351239807)
35. Mehrabi A, Kashfi A, Fonouni H, Schemmer P, Schmied BM, Hallscheidt P, et al. Primary malignant hepatic epithelioid hemangioendothelioma: a comprehensive review of the literature with emphasis on the surgical therapy. Cancer 2006; 107: 2108-2121. (Pubitemid 44665643)
36. Kim DY, Kim KH, Jung SE, Lee SC, Park KW, Kim WK,. Undifferentiated (embryonal) sarcoma of the liver: combination treatment by surgery and chemotherapy. J Pediatr Surg 2002; 37: 1419-1423.
37. Okajima H, Ohya Y, Lee KJ, Yamamoto H, Asonuma K, Nagaoki Y, et al. Management of undifferentiated sarcoma of the liver including living donor liver transplantation as a backup procedure. J Pediatr Surg 2009; 44: e33-e38.
38. Dimashkieh HH, Mo JQ, Wyatt-Ashmead J, Collins MH,. Pediatric hepatic angiosarcoma: case report and review of the literature. Pediatr Dev Pathol 2004; 7: 527-532. (Pubitemid 40385243)